Alveo (Diagnostic Equipment) key facts
as of Oct 2026- Developer of diagnostics technology designed to address global challenges and opportunities surrounding infectious diseases.
- Alveo (Diagnostic Equipment) is valued at approximately $116.0M as of Oct 2026 (last reported valuation).
- It has raised $83.6M; the latest was Later Stage VC in Jun 2025.
- Notable investors include Gates Foundation, Celesta Capital, Black Diamond Ventures, Seed-Resolute, Opaleye — 14 tracked in total.
- Status: Privately Held (backing).
Alveo (Diagnostic Equipment)'s last reported valuation, Mar 2021. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Alveo (Diagnostic Equipment): the Monday email on marks, rounds and moves
Alveo (Diagnostic Equipment) funding rounds
No funding rounds for Alveo (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Alveo (Diagnostic Equipment)
14+Alveo (Diagnostic Equipment) valuation
Alveo (Diagnostic Equipment)'s last reported valuation was $116 million in Mar 2021. No priced round, secondary trade or fund mark has surfaced since.
Alveo (Diagnostic Equipment) investors
14 investors are on record for Alveo (Diagnostic Equipment), including Gates Foundation, Celesta Capital, Black Diamond Ventures and Seed-Resolute.
About Alveo (Diagnostic Equipment)
Developer of diagnostics technology designed to address global challenges and opportunities surrounding infectious diseases. The company's cloud-strengthened technology helps in the creation of vast datasets in order to track global infectious disease outbreaks and connect individuals with treatments, enabling consumers, healthcare professionals, and treatment providers with the ability to detect a range of diseases that threaten public health.
- Sector
- Healthcare
- HQ
- Alameda, CA, United States
- Founded
- 2014
- Employees
- 67
- Website
- alveotechnologies.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.